News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
142,363 Results
Type
Article (4604)
Company Profile (95)
Press Release (137659)
Multimedia
Podcasts (4)
Webinars (7)
Section
Business (43365)
Career Advice (212)
Deals (6357)
Drug Delivery (16)
Drug Development (20170)
Employer Resources (18)
FDA (1589)
Job Trends (2866)
News (70137)
Policy (3809)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (302)
Accelerated approval (8)
Adcomms (1)
Allergies (32)
Alliances (11650)
ALS (62)
Alzheimer's disease (517)
Antibody-drug conjugate (ADC) (101)
Approvals (1673)
Artificial intelligence (107)
Autoimmune disease (67)
Automation (12)
Bankruptcy (38)
Best Places to Work (2316)
BIOSECURE Act (14)
Biosimilars (26)
Biotechnology (86)
Bladder cancer (44)
Brain cancer (14)
Breast cancer (191)
Cancer (1366)
Cardiovascular disease (57)
Career advice (204)
Career pathing (5)
CAR-T (122)
Cell therapy (317)
Cervical cancer (9)
Clinical research (18089)
Collaboration (569)
Compensation (279)
Complete response letters (5)
COVID-19 (464)
CRISPR (26)
C-suite (362)
Cystic fibrosis (61)
Data (2138)
Depression (22)
Diabetes (119)
Diagnostics (756)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (95)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (64)
Earnings (14483)
Editorial (5)
Employer resources (18)
Events (27002)
Executive appointments (384)
FDA (2314)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (14)
Funding (493)
Gene editing (57)
Generative AI (12)
Gene therapy (175)
GLP-1 (190)
Government (375)
Guidances (78)
Healthcare (1625)
HIV (8)
Huntington's disease (14)
IgA nephropathy (41)
Immunology and inflammation (76)
Immuno-oncology (14)
Indications (24)
Infectious disease (520)
Inflammatory bowel disease (80)
Inflation Reduction Act (1)
Influenza (34)
Intellectual property (80)
Interviews (19)
IPO (3121)
IRA (4)
Job creations (678)
Job search strategy (185)
JPM (4)
Kidney cancer (3)
Labor market (16)
Layoffs (48)
Leadership (2)
Legal (645)
Liver cancer (18)
Longevity (2)
Lung cancer (124)
Lymphoma (147)
Machine learning (15)
Management (4)
Manufacturing (244)
MASH (20)
Medical device (429)
Medtech (431)
Mergers & acquisitions (3581)
Metabolic disorders (270)
Multiple sclerosis (54)
NASH (2)
Neurodegenerative disease (93)
Neuropsychiatric disorders (19)
Neuroscience (884)
Neurotech (1)
NextGen: Class of 2026 (880)
Non-profit (287)
Now hiring (7)
Obesity (123)
Opinion (46)
Ovarian cancer (68)
Pain (56)
Pancreatic cancer (75)
Parkinson's disease (120)
Partnered (6)
Patents (134)
Patient recruitment (163)
Peanut (17)
People (17250)
Pharmaceutical (8)
Phase 1 (8095)
Phase 2 (8161)
Phase 3 (3994)
Pipeline (1568)
Policy (33)
Postmarket research (223)
Preclinical (2725)
Press Release (51)
Prostate cancer (48)
Psychedelics (5)
Radiopharmaceuticals (54)
Rare diseases (194)
Real estate (1468)
Recruiting (10)
Regulatory (3602)
Reports (15)
Research institute (322)
Resumes & cover letters (21)
Rett syndrome (9)
RNA editing (5)
RSV (13)
Schizophrenia (27)
Series A (94)
Series B (74)
Service/supplier (2)
Sickle cell disease (25)
Special edition (3)
Spinal muscular atrophy (43)
Sponsored (5)
Startups (1001)
State (1)
Stomach cancer (2)
Supply chain (22)
Tariffs (9)
The Weekly (4)
Vaccines (123)
Venture capital (19)
Weight loss (52)
Women's health (8)
Worklife (2)
Date
Last 7 days (152)
Last 30 days (587)
Last 365 days (8917)
2026 (814)
2025 (9013)
2024 (9650)
2023 (10499)
2022 (12730)
2021 (13384)
2020 (10373)
2019 (7022)
2018 (5519)
2017 (6337)
2016 (5842)
2015 (6710)
2014 (5089)
2013 (4152)
2012 (4519)
2011 (4989)
2010 (4609)
Location
Africa (146)
Alabama (54)
Alaska (1)
Arizona (35)
Arkansas (2)
Asia (9276)
Australia (2134)
California (3796)
Canada (941)
China (290)
Colorado (78)
Connecticut (130)
Delaware (60)
Europe (20300)
Florida (398)
Georgia (70)
Hawaii (2)
Idaho (11)
Illinois (186)
India (17)
Indiana (209)
Iowa (3)
Japan (108)
Kansas (15)
Kentucky (3)
Louisiana (5)
Maine (2)
Maryland (392)
Massachusetts (2889)
Michigan (97)
Minnesota (157)
Mississippi (1)
Missouri (11)
Montana (10)
Nebraska (2)
Nevada (23)
New Hampshire (7)
New Jersey (722)
New Mexico (6)
New York (832)
North Carolina (452)
North Dakota (5)
Northern California (1862)
Ohio (69)
Oklahoma (7)
Oregon (8)
Pennsylvania (668)
Puerto Rico (8)
Rhode Island (5)
South America (205)
South Carolina (4)
Southern California (1495)
Tennessee (23)
Texas (484)
United States (12018)
Utah (39)
Virginia (29)
Washington D.C. (9)
Washington State (546)
West Virginia (1)
Wisconsin (24)
142,363 Results for "ascendance biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
December 10, 2025
·
2 min read
Press Releases
SCYNEXIS Announces Positive Results from a Phase 1, Single Ascending Dose and Multiple Ascending Dose Study of its Second-Generation Fungerp (SCY-247)
October 1, 2025
·
4 min read
Press Releases
DemeRx Announces Successful Completion of Multiple Ascending Dose Clinical Trial of DMX-1001 for the Treatment of Alcohol Use Disorder (AUD)
January 6, 2026
·
3 min read
Press Releases
MavriX Bio Announces First Patient Dosed in ASCEND-AS Trial of MVX-220, Investigational Gene Therapy for Angelman Syndrome
November 7, 2025
·
4 min read
Press Releases
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
August 20, 2025
·
6 min read
Press Releases
European Patent on Ascend Advanced Therapies’ EpyQ® AAV Plasmid Technology Successfully Defended at the EPO
October 9, 2025
·
2 min read
Press Releases
At RSNA 2025, ASCEND Cardiovascular and Konica Minolta Healthcare Announce Partnership to Deliver a Best-in-Class Enterprise Imaging Solution that Elevates Cardiovascular Care
December 1, 2025
·
4 min read
Press Releases
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)
December 23, 2025
·
3 min read
Press Releases
Onco3R Therapeutics Announces Completion of First Multiple Ascending Dose Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671
December 3, 2025
·
4 min read
Press Releases
Ascend Aesthetic Partners Welcomes David Cutter as COO
May 30, 2025
·
2 min read
1 of 14,237
Next
